Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for NCT04427774 is displayed, describing the surufatinib–sintilimab study, its terminated status, participant criteria, treatment plan, outcome measures, and record dates.
    Difference
    32%
    Check dated 2026-11-08T04:38:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error rather than the study record. The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T01:47:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about updated terminology for artificial intelligence appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-25T01:43:46.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:33:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:00:59.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the previous study record content with a basic site layout indicating access is blocked.
    Difference
    15%
    Check dated 2026-09-20T00:57:47.000Z thumbnail image

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.